一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ 内部交易: 2017-02-21,See Remarks,Sarpangal Zeryn ,卖出,439普通股, $22.76
$Achaogen(AKAO)$ 内部交易: 2017-02-21,SVP, Chief Medical Officer,Friedland Ian ,卖出,1026普通股, $22.76
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001104659-17-009240 Size: 166 KB 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001072613-17-000144 Size: 58 KB 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0000315066-17-001370 Size: 9 KB 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001178913-17-000400 Size: 153 KB 网页链接
$Achaogen(AKAO)$ 内部交易: 2017-01-26,CEO,Hillan Kenneth J. ,卖出,1431普通股, $16.78
$Achaogen(AKAO)$ 内部交易: 2017-01-26,Chief Medical Officer,Friedland Ian ,卖出,695普通股, $16.78
$Achaogen(AKAO)$ 内部交易: 2017-01-26,VP, HR and Corporate Affairs,Sarpangal Zeryn ,卖出,781普通股, $16.78
$Achaogen(AKAO)$ 内部交易: 2017-01-26,General Counsel,LOEB GARY ,卖出,521普通股, $16.78